Injection of the sciatic nerve with TMEV: A new model for peripheral nerve demyelination

Virology

Volumn 359, Issue 1, 2007, Pages 233-242

  Drescher, Kristen M ^a   Tracy, Steven M ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Peripheral demyelination; Sciatic nerve; TMEV

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVIRUS; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; FEMALE; GENETIC DISORDER; HINDLIMB; INFLAMMATORY CELL; INOCULATION; MACROPHAGE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; SPINAL CORD; VIRUS REPLICATION;

ANIMALS; CARDIOVIRUS INFECTIONS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; PARALYSIS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SCHWANN CELLS; SCIATIC NERVE; SCIATIC NEUROPATHY; SPINAL CORD; THEILOVIRUS; TIME FACTORS;

ANIMALIA; CARDIOVIRUS; MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 33846857968     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.009     Document Type: Article

References (94)

1. Bernhardt G., Bibb J.A., Bradley J., and Wimmer E. Molecular characterization of the cellular receptor for poliovirus. Virology 199 (1994) 105-113
2. Bitan M., Or R., Shapira M.Y., Mador N., Resnick I.B., Saleh N., Weinberger K.M., Samuel S., Schechter E., Slavin S., and Wolf D.G. Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin. Infect. Dis. 39 (2004) 1076-1078
3. Bosma G.C., Custer R.P., and Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature 301 (1983) 527-530
4. Bour-Jordan H., Thompson H.L., and Bluestone J.A. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice. J. Immunol. 175 (2005) 5649-5655
5. Brannagan III T.H., and Zhou Y. HIV-associated Guillain-Barre syndrome. J. Neurol. Sci. 208 (2003) 39-42
6. Clatch R.J., Miller S.D., Metzner R., Dal Canto M.C., and Lipton H.L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176 (1990) 244-254
7. Dal Canto M.C., and Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 33 (1975) 626-637
8. Drescher K.M., Nguyen L.T., Taneja V., Coenen M.J., Leibowitz J.L., Strauss G., Hammerling G.J., David C.S., and Rodriguez M. Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. J. Clin. Invest. 101 (1998) 1765-1774
9. Drescher K.M., Murray P.D., David C.S., Pease L.R., and Rodriguez M. CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol. 9 (1999) 21-31
10. Drescher K.M., Murray P.D., Lin X., Carlino J.A., and Rodriguez M. TGF-β2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. J. Immunol. 164 (2000) 3207-3213
11. Drescher K.M., Zoecklein L., Pavelko K.D., Rivera-Quinones C., Hollenbaugh D., and Rodriguez M. CD40L is critical for protection from demyelinating disease and development of spontaneous remyelination in a mouse model of multiple sclerosis. Brain Pathol. 10 (2000) 1-15
12. Drescher K.M., Kono K., Bopegamage S., Carson S.D., and Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329 (2004) 381-394
13. Faber M., Pulmanausahakul R., Nagao K., Prosniak M., Rice A.B., Koprowski H., Schnell M.J., and Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16328-16332
14. Ferrari S., Vento S., Monaco S., Cavallaro T., Cainelli F., Rizzuto N., and Temesgen Z. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin. Proc. 81 (2006) 213-219
15. Fiette L., Aubert C., Muller U., Huang S., Auget M., Brahic M., and Bureau J.F. Theiler's virus infection of 129 Sv mice that lack the interferon α/β or interferon γ receptors. J. Exp. Med. 181 (1995) 2069-2076
16. Frankel G., Friedmann A., Amir A., David Y., and Shahar A. Theiler's virus replication in isolated Schwann cell cultures. J. Neurosci. Res. 15 (1986) 127-136
17. Fujiki N., and Tashiro K. Herpes viruses--herpes simplex virus, varicella-zoster virus, EB virus, cytomegalovirus. Nippon Rinsho 55 (1997) 855-860
18. Gupta S.K., Pringle J., Poduslo J.F., and Mezei C. Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control. J. Neurochem. 56 (1991) 1754-1762
19. Hemachudha T., Wacharapluesadee S., Mitrabhakdi E., Wilde H., Morimoto K., and Lewis R.A. Pathophysiology of human paralytic rabies. J. Neurovirol. 11 (2005) 93-100
20. Hulgan T., Haas D.W., Haines J.L., Ritchie M.D., Robbins G.K., Shafer R.W., Clifford D.B., Kallianpur A.R., Summar M., and Canter J.A. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trails group study. AIDS 19 (2005) 1341-1349
21. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., Chang S., Braun M.M., and Ball R. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 294 (2005) 2720-2725
22. Jin L., Perng G.C., Brick D.J., Naito J., Nesburn A.B., Jones C., and Weschler S.J. Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells. J. Virol. Methods 118 (2004) 9-13
23. Jnaoui K., and Michiels T. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains. J. Virol. 73 (1999) 7248-7254
24. Jnaoui K., Minet M., and Michiels T. Mutations that affect the trophism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J. Virol. 76 (2002) 8138-8147
25. Kawczak J.A., Mathisen P.M., Drazba J.A., Fuss B., Macklin W.B., and Tuohy V.K. Digitized image analysis reveals diffuse abnormalities in normal-appearing white matter during acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 54 (1998) 364-372
26. Khademi M., Illes Z., Gielen A.W., Marta M., Takazawa N., Baecher-Allan C., Brundin L., Hannerz J., Martin C., Harris R.A., Hafler D.A., Kuchroo V.K., Olsson T., Piehl F., and Wallstrom E. T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J. Immunol. 172 (2004) 7169-7176
27. Khamaisi M., Shoenfeld Y., and Orbach H. Guillain-Barre syndrome following hepatitis B vaccination. Clin. Exp. Rheumatol. 22 (2004) 767-770
28. Koga M., Gilbert M., Li J., Koike S., Takahashi M., Furukawa K., Hirata K., and Yuki N. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64 (2005) 1605-1611
29. Levine J., Buchman C.A., and Fregien N. Influenza A virus infection of human Schwann cells in vitro. Acta Oto-Laryngol. 123 (2003) 41-45
30. Libbey J.E., McCright I.J., Tsunoda I., Wada Y., and Fujinami R.S. Peripheral nerve protein, PO, as a potential receptor for Theiler's murine encephalomyelitis virus. J. Neurovirol. 7 (2001) 97-104
31. Lindsay M.D., and Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142 (1989) 2677-2682
32. Lindsley M.D., Thiemann R.L., and Rodriguez M. Enumeration and distribution of T-cell subsets, macrophages, and IgG positive cells in the CNS of SJL/J mice infected with Theiler's virus. Ann. N.Y. Acad Sci. 540 (1988) 657-660
33. Lindsley M.D., Thiemann R., and Rodriguez M. Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 65 (1991) 6612-6620
34. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11 (1975) 1147-1155
35. Lipton H.L., and Dal Canto M.C. Theiler's virus-induced demyelination: prevention by immunosuppression. Science 192 (1976) 62-64
36. Lipton H.L., and Dal Canto M.C. Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect. Immun. 15 (1977) 903-909
37. Lipton H.L., and Dal Canto M.C. The TO strains of Theiler's viruses cause 'slow-virus like' infection in mice. Ann. Neurol. 6 (1979) 25-28
38. Male D., Pryce G., Hughes C., and Lantos P. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell. Immunol. 127 (1990) 1-11
39. Male D., Pryce G., and Rahman J. Comparison of the immunological properties of rat cerebral and aortic endothelium. J. Neuroimmunol. 30 (1990) 161-168
40. Male D., Pryce G., Linke A., and Rahman J. Lymphocyte migration into the CNS modelled in vitro. J. Neuroimmunol. 40 (1992) 167-171
41. Martinat C., Jarousse N., Prevost M.C., and Brahic M. The GDVII strain of Theiler's virus spreads via axonal transport. J. Virol. 73 (1999) 6093-6098
42. McCright I.J., Tsunoda I., Whitby F.G., and Fujinami R.S. Theiler's viruses with mutations in loop I of VP1 lead to altered trophism and pathogenesis. J. Virol. 73 (1999) 2814-2824
43. Medhurst A.D., Harrison D.C., Read S.J., Campbell C.A., Robbins M.J., and Pangalos M.N. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 98 (2000) 9-20
44. Meekins G.D., Emery M.J., and Weiss M.D. Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?. J. Peripher. Nerv. Syst. 9 (2004) 177-182
45. Mendelsohn C.L., Wimmer E., and Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of new member of the immunoglobulin superfamily. Cell 56 (1989) 855-865
46. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Neville K.L., Yauch R.L., and Kim B.S. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J. Neurovirol. 3 (1997) S62-S65
47. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., and Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3 (1997) 1133-1136
48. Moon C., Kim H., Ahn M., Jin J.-K., Wang H., Matsumoto Y., and Shin T. Enhanced expression of netrin-1 protein in the sciatic nerves of Lewis rats with experimental autoimmune neuritis: possible role of the netrin-1/DCC binding pathway in an autoimmune disorder. J. Neuroimmunol. 172 (2006) 66-72
49. Murray P.D., McGavern D.B., Lin X., Njenga M.K., Leibowitz J., Pease L.R., and Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18 (1998) 7306-7314
50. Nien J.K., Schmidt J., Cartier L., and Alverez J. Cerebrospinal fluid of HTLV-1 associated myelopathy patients induces axonal sproutings and Schwann cell proliferation in the rat sciatic nerve. J. Neurol. Sci. 159 (1998) 17-24
51. Njenga M.K., Asakura K., Wettstein P., Pease L.R., and Rodriguez M. Immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 71 (1997) 8592-8601
52. Njenga M.K., Marques C., and Rodriguez M. The role of cellular immune response in Theiler's virus-induced central nervous system demyelination. J. Neuroimmunol. 147 (2004) 73-77
53. Ohka S., Yang W.-X., Terada E., Iwasaki K., and Nomoto A. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 250 (1998) 67-75
54. Ozden S., Aubert C., Bureau J.F., Gonzalez-Dunia D., and Brahic M. Analysis of proteolipid protein and Po transcripts in mice infected with Theiler's virus. Microb. Pathog. 14 (1993) 123-131
55. Palmer J.A., Branston R.H., Lilley C.E., Robinson M.J., Groutsi F., Smith J., Latchman D.S., and Coffin R.S. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J. Virol. 74 (2000) 5604-5618
56. Patick A.K., Pease L.R., David C.S., and Rodriguez M. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64 (1990) 5570-5576
57. Pavone P., Maccarrone F., Sorge A., Piccolo G., Greco F., Caruson P., and Sorge G. Guillain-Barre syndrome after varicella zoster virus infections. A case report. Minerva Pediatr. 54 (2002) 259-262
58. Paya C.V., Leibson P.J., Patick A.K., and Rodriguez M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2 (1990) 909-913
59. Pena Rossi C., McAllister A., Fiette L., and Brahic M. Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell Immunol. 138 (1991) 341-348
60. Pena Rossi C., Delcroix M., Huitinga I., McAllister A., Van Rooijen N., Claassen E., and Brahic M. Role of macrophages during Theiler's virus infection. J. Virol. 71 (1997) 3336-3340
61. Pevear D.C., Calendoff M., Rozhon E., and Lipton H.L. Analysis of the complete nucleotide sequences of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J. Virol. 61 (1987) 1507-1516
62. Pevear D.C., Borkowski J., Calendoff M., Oh C.K., Ostrowski B., and Lipton H.L. Insights into Theiler's virus neurovirulence based on genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 165 (1988) 1-12
63. Ponticelli C., and Campise M.R. Neurological complications in kidney transplant recipients. J. Nephrol. 18 (2005) 521-528
64. Rao V.K., and Thomas F.P. Neurological complications of HIV/AIDS. Beta 17 (2005) 37-46
65. Ren R., and Racaniello V.R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166 (1992) 747-752
66. Roccatagliata L., Uccelli A., and Murialdo A. Guillain-Barre syndrome after reactivation of varicella-zoster virus. N. Eng. J. Med. 344 (2001) 65-66
67. Rodriguez M. The cellular immune response and pathogenesis of Theiler's virus-induced demyelination. In: Thomas D. (Ed). Viruses and the Cellular Immune Response (1993), Marcel Dekker Inc., New York 473-489
68. Rodriguez M., and David C.S. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135 (1985) 2145-2148
69. Rodriguez M., and Sriram S. Successful therapy of TMEV-induced demyelination (DA strain) with monoclonal anti lyt2.2 antibody. J. Immunol. 140 (1988) 2950-2955
70. Rodriguez M., Leibowitz J., and David C.S. Susceptibility to Theiler's virus-Induced demyelination: mapping of the gene within the H-2D region. J. Exp. Med. 163 (1986) 620-631
71. Rodriguez M., Dunkel A.J., Thiemann R.L., Leibowitz J., Zijlstra M., and Jaenisch R. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in β2-microglobulin. J. Immunol. 151 (1993) 266-276
72. Rodriguez M., Nabozny G.H., Thiemann R.L., and David C.S. Influence of deletion of T cell receptor Vβ genes on the Theiler's virus model of multiple sclerosis. Autoimmunity 19 (1994) 221-230
73. Rodriguez M., Prayoonwiwat N., Howe C., and Sanborn K. Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis. J. Neuropathol. Exp. Neurol. 53 (1994) 136-143
74. Rodriguez M., Pavelko K.D., and Coffman R.L. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69 (1995) 7286-7290
75. Rodriguez M., Rivera-Quinones C., Murray P.D., Njenga M.K., Wettstein P.J., and Mak T. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. J. Neurovirol. 3 (1997) S43-S45
76. Rustigian R., and Pappenheimer A.M. Myositis in mice following intramuscular injection of viruses of the mouse encephalomyelitis group and of certain other neurotrophic viruses. J. Exp. Med. 89 (1949) 69-92
77. Sabin A.B. Pathogenesis of poliomyelitis. Science 123 (1956) 1151-1157
78. Sabin A.B., and Ward R. The natural history of human poliomyelitis: I. Distribution of virus in nervous and non-nervous system tissue. J. Exp. Med. 73 (1941) 771-793
79. Shah A.H., and Lipton H.L. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology 304 (2002) 443-450
80. Solomon T., and Willison H. Infectious causes of acute flaccid paralysis. Curr. Opin. Infect. Dis. 16 (2003) 375-381
81. Song G.Y., and Jia W. The heterogeneity in the immune response and efficiency of viral dissemination in brain infected with herpes simplex virus type 1 through peripheral or central route. Acta Neuropathol. (Berl.) 97 (1999) 649-656
82. Tababella G., and Nowzari H. Cytomegalovirus-associated peridontitis and Guillain-Barre syndrome. J. Peridontol. 76 (2005) 2306-2311
83. Takahashi K., Kunishige M., Shinohara M., Kubo K., Inoue H., Yoshino H., Asano A., Honda S., Matsumoto T., and Mitsui T. Guillain-Barre syndrome and hemophagocytic lymphohistocytosis in a patient with severe chronic active Epstein-Barr virus infection syndrome. Clin. Neurol. Neurosurg. 108 (2005) 80-83
84. Tanimura N., Imada T., Kashiwazaki Y., Shahirudin S., Sharifah S.H., and Aziz A.J. Monoclonal antibody-based immunohistochemical diagnosis of Malaysian Nipah virus infection in pigs. J. Comp. Pathol. 131 (2004) 199-206
85. Theiler M. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65 (1940) 705-719
86. Theiler M., and Gard S. Encephalomyelitis of mice: III. Epidemiology. J. Exp. Med. 72 (1940) 79-90
87. Tracy S., Drescher K.M., Chapman N.M., Kim K.S., Carson S.D., Pirruccello S., Lane P.H., Romero J.R., and Leser J.S. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76 (2002) 12097-12111
88. Tsunoda I., Wada Y., Libbey J.E., Cannon T.S., Whitby F.G., and Fujinami R.S. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J. Virol. 75 (2001) 7494-7505
89. van Rijk A.F., Sweers M.A.M., Merkx G.F.M., Lammens M., and Bloemendal H. Pathogenesis of axonal dystrophy and demyelination in α-A-crystillin-expressing transgenic mice. Int. J. Exp. Pathol. 84 (2003) 91-99
90. Watanabe T.S., Ohtori S., Koda M., Aoki Y., Doya H., Shirasawa H., Yamazaki M., Moriya H., Takahashi K., and Yamahita T. Adenoviral gene transfer in the peripheral nervous system. J. Orthop. Sci. 11 (2006) 64-69
91. Wekerle H., Linington C., Lassmann H., and Meyermann R. Cellular immune reactivity within the CNS. TINS 8 (1986) 271-277
92. Yaghootfam A., Gieselman V., and Eckhardt M. Delay of myelin formation in arylsulphatase A-deficient mice. Eur. J. Neurosci. 21 (2005) 711-720
93. Zhou L., Luo Y., Wu Y., Tsao J., and Luo M. Sialylation of the host receptor may modulate entry of the demyelinating persistent Theiler's virus. J. Virol. 74 (2000) 1929-1937
94. Zhu Y., Ljunggren H.G., Mix E., Li H.L., van der Meide P., Elhassan A.M., Winblad B., and Zhu J. Suppression of autoimmune neuritis in IFN-γ receptor-deficient mice. Exp. Neurol. 169 (2001) 472-478